A major breakthrough in cancer research is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This essential tumor inhibitor protein is frequently inactivated in many kinds of cancer, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research